The serum protein histidine-rich glycoprotein (HRG) -concentration-and pH-dependent manner. Our data highlight the complex divalent metal-dependent regulatory mechanisms that govern HRG function.
The serum protein histidine-rich glycoprotein (HRG) has been implicated in tissue injury and tumour growth. Several HRG functions are regulated by the divalent metal Zn 2+ , including ligand binding and proteolytic processing that releases active HRG fragments. Although HRG can bind divalent metals other than Zn 2+ , the impact of these divalent metals on the biophysical properties of HRG remains poorly understood. We now show that HRG binds Zn 2+ , Ni 2+ , Cu 2+ and Co 2+ with micromolar affinities, but differing stoichiometries, and regulate the release of specific HRG fragments during proteolysis. Furthermore, HRG binding to Zn 2+ promotes HRG dimer formation in a Zn 2+ -concentration-and pH-dependent manner. Our data highlight the complex divalent metal-dependent regulatory mechanisms that govern HRG function.
Keywords: divalent metals; histidine-rich glycoprotein; zinc Histidine-rich glycoprotein (HRG) is a relatively abundant serum protein that is secreted by liver parenchymal cells [1] . HRG has the capacity to associate with a strikingly large number of ligands through its multidomain structure to facilitate various immunological and vascular functions normally associated with sites of tissue injury and tumour growth. The multidomain structure of HRG is predicted to comprise of two cystatinlike homology domains (N1N2), two proline-rich regions (PRR1, PRR2), a C-terminal domain and a histidine-rich region (HRR) as its central core that has metal binding and pH sensing properties [2] [3] [4] [5] . The central core comprises tandem repeats of GHHPH-like motifs, with this region commonly reported to regulate ligand affinity and function upon Zn 2+ coordination or when positively charged under acidic conditions [1, 4] . In normal homeostatic conditions, the presence of free Zn 2+ is relatively low (0.1-2.0 lM), as most remains bound to either albumin or a-macroglobulin [6] [7] [8] [9] . This likely leaves HRG primary source of Zn 2+ from degranulating platelets, where it has been suggested to regulate HRG function in the formation of immune complexes, apoptotic/necrotic and pathogen clearance, as well as coagulation and fibrinolysis [4, 8, 10, 11] . Two separate studies have reported the affinity of HRG for Zn 2+ as K d 4 lM or 12.41 lM, respectively, with both suggesting a stoichiometry of 10 [12, 13] . The binding of other divalent metals to HRG has also been demonstrated based on the capacity to displace bound haem. This indirect assay described the order of divalent metal binding to HRG as Cu 2+ > Zn 2+ > Ni 2+ > Cd 2+ > Co
2+
. Additional studies of rbHRG have also suggested the ability to bind mercury (Hg 2+ ) [14, 15] . These studies demonstrate that HRG has the potential to coordinate with a range of divalent metals, which as described for Zn 2+ may also regulate HRG function, particularly as the levels of divalent metals are increased in various physiological and pathological processes that HRG contributes [8, 16] . For example, the divalent metals Zn 2+ , Cu 2+ and Ni 2+ have been reported as being up-regulated in the serum of cancer patients, with the levels showing variation based on the type of cancer [16] . However, despite the ability of HRG to coordinate with divalent metals that may differentially regulate its function(s), with the exception of the interaction with Zn 2+ , there remains a distinct lack of understanding of the interactions with the other divalent metals from a biophysical perspective.
The central HRR of HRG is responsible for regulating Zn 2+ coordination and therefore HRG function. Within the HRG tandem GHHPH-like motif, the nitrogen of the histidines acts as a ligand donor for Zn 2+ binding, which also exhibits preference to Zn 2+ ions over other divalent metals [17, 18] . Interestingly, the examination of proteins that have the capacity to form higher order quaternary structures in the presence of a range of divalent metals revealed Zn 2+ as the prime mediator [19] . Additionally, it has been well established that acidic pH displaces Zn 2+ from the HRR of HRG, as protonation of the histidines prevents nitrogen participating as a ligand donor for Zn 2+ [15, 20] . This ability of Zn 2+ to modulate HRG ligand recognition and affinity has also been observed to regulate proteolysis, as HRG bound with Zn 2+ is protected from the serine protease plasmin that would otherwise cleave HRG and alter its function [4, 21] . There are multiple reports demonstrating that the proteolytic release of individual domains from HRG is necessary to mediate antimicrobial, antiangiogenic and endotoxin-neutralizing abilities that are masked in the intact protein [22] [23] [24] [25] [26] [27] . It should be noted that in some settings, HRG proteolysis still persists in the presence of Zn 2+ , such as observed in the serum of cancer patients [27] . However, the protease responsible for mediating the release of these potentially active domains remains unclear [27] . Collectively, these findings illustrate that the surrounding environment plays an important role in controlling the function of HRG through changes in pH and subsequent Zn 2+ coordination and/or proteolysis, which in turn can regulate ligand recognition. As such, HRG is commonly defined as a pHsensing adaptor molecule [1, 3, 4, 15, 20, 21] .
In this study, we have used a range of methods to assess the biophysical characteristics of HRG when bound to divalent metals. Using ITC, HRG was found to preferentially bind Zn
Trypsin treatment of HRG bound to Cu 2+ , Ni 2+ , Co 2+ and Zn 2+ , resulted in the release of peptide fragments, with the number and size of fragments differing for each HRG-divalent metal complex. The oligomeric state of HRG upon divalent metal coordination was also assessed using size exclusion chromatography (SEC) and revealed that only Zn 2+ was able to mediate a higher order quaternary structure as indicated by the formation of HRG dimers. Furthermore, HRG dimer formation was regulated by the concentration of Zn 2+ and pH. These data suggest that the types of divalent metals coordinated with HRG, in combination with proteolytic processing and changes in pH, alter the state of HRG that will likely regulate its function at specific sites such as tissue injury and tumour growth.
Materials and methods

Purification of HRG from human plasma
Histidine-rich glycoprotein was purified from human serum as previously described [28] , with additional modifications to the protocol involve purifying HRG by € AKTA pure system using a Superdex 
Inductively coupled plasma mass spectrometry
The inductively coupled plasma mass spectrometry (ICP-MS; Agilent Technologies, Santa Clara, CA, USA 7700e Series) was performed using the collision reaction cell under He gas according to the manufacturer's instructions. Initially, to identify the concentration of the divalent metals bound with HRG from the purification procedure, standards were prepared. These standards involved spiking the buffer [20 mM Bis-Tris HCl (pH 7.4), 150 mM NaCl, SIGMA-Aldrich] with divalent metals (ZnCl 2 , CuCl 2 , NiCl 2 and CoCl 2 , SIGMAAldrich) of a known concentration (Table S1 ), which were serial diluted (1 : 10, 1 : 100, 1 : 1000, 1 : 10 000) into 2% nitric acid. The HRG sample was prepared by a serial dilution (1 : 100) into 2% nitric acid, prior to ICP-MS analysis (Table S1 ). The divalent metals were quantified from the measured signal after subtracting the nitric acid (2%) as the blank signal.
Preparation of divalent metals
Two hundred millimolar of ZnCl 2 (SIGMA-Aldrich) and 100 mM of CuCl 2 (SIGMA-Aldrich), were dissolved into Chelex-100 (Bio-Rad laboratories, Hercules, CA, USA) treated Bis-Tris HCl buffer (20 mM Bis-Tris HCl, 150 mM NaCl, pH 7.4), prior to being serial diluted to the desired concentration.
While for the divalent metals NiCl 2 (SIGMA-Aldrich) and CoCl 2 (SIGMA-Aldrich) were first dissolved at 1 M in Chelex-100 (Bio-Rad laboratories) treated HEPES buffer (20 mM HEPES, 150 mM NaCl, 0.1 M HCl, pH 7.4), prior to being serial diluted in Chelex-100 (Bio-Rad) treated HEPES buffer (20 mM HEPES, 150 mM NaCl, pH 7.4) to the desired concentration. 
Isothermal titration calorimetry
Effect of divalent metals on HRG by trypsin proteolysis
Trypsin (0.2 lg) (SIGMA) digests over the time course (1, 3, 15, 30, 60 s) to HRG (7.5 lg/5.6 lM) were performed in 20 mM Bis-Tris HCl, 150 mM NaCl (pH 7.4) alone and for ZnCl 2 (50 lM or 112.6 lM) or CuCl 2 (50 lM) and 20 mM HEPES, 150 mM NaCl (pH 7.4) for CoCl 2 (50 lM) or NiCl 2 (50 lM). The trypsin digest reaction was terminated by heating at 100°C for 2 min, prior to adding SDS loading dye (reducing, 50 mM DTT or nonreducing, no DTT). Samples were evaporated to < 20 lL, prior to loading the total remaining volume of the samples onto a 15% SDS/PAGE.
Effect on trypsin proteolysis of IgG in the presence of divalent metals
To ensure that trypsin is not affected by the concentration of divalent metals used in this study, pooled IgG (SIGMAAldrich) was used a control substrate for trypsin due to its low affinity for divalent metals [29] . Trypsin (0.2 lg) digests of IgG (7.5 lg) were performed in 20 mM Bis-Tris HCl, 150 mM NaCl (pH 7.4) alone and for ZnCl 2 (50 lM) or CuCl 2 (50 lM). Additionally, to examine the affects of CoCl 2 (50 lM) and NiCl 2 (50 lM) on trypsin for IgG, the buffer was changed to 20 mM HEPES, 150 mM NaCl (pH 7.4).
Oligomeric assessment of HRG, in the presence of divalent metals using size exclusion chromatography
Chromatography profiles were obtained using a € AKTA pure system, with a Superdex TM 200 Increase 3.2/300 at a flow rate of 0.075 mLÁmin
À1
. HRG was loaded to the column using a 4 lL loop at 5 mgÁmin
. The protein was detected at 280 nm, with the molecular weights determined based on standards ( 
Results
Divalent metal content of plasma purified human HRG
Serum proteins are notoriously difficult to purify to homogeneity, primarily due to the large abundance of potential contaminating proteins. We have previously addressed the issue for the serum protein HRG by optimizing a protocol for its efficient purification of HRG to homogeneity [28] . However, this purification procedure does not take into account that HRG may be associated with residual divalent metals, obtained either endogenously from serum or from immobilized metal affinity chromatography [28] .
To address the possibility of residual divalent metal contamination, HRG was treated with EDTA. To assess if EDTA treatment of HRG was sufficient to remove residual divalent metals, ICP-MS analysis was employed. HRG was found to contain only low levels of divalent metals from the purification procedure (Table 1) . Taken together with the divalent metal stoichiometries from the ITC analysis (Table 2 ), the concentrations observed from ICP-MS for each individual or sum of divalent metals bound to HRG would be insufficient to saturate a single metal-binding site. This indicates the concentration of divalent metals in the EDTA-treated HRG sample is negligible and will not impact further studies.
The significance in treating HRG with EDTA was underscored further by SEC analysis, with EDTA treatment resulting in a change to the elution profile of HRG from an irregular multipeak (Fig. 1A) to a single symmetrical monomer peak profile (Fig. 1B) . This infers that postpurification HRG still remained in complex with divalent metals and EDTA treatment removes residual metals to produce a single species. Therefore, these data suggest that the serum-purified HRG is likely complexed with residual divalent metals during the purification procedure. As such, EDTA treatment of HRG is a necessary step to purify HRG to homogeneity when investigating HRG functional or biophysical properties. -dependent functions of HRG have been extensively investigated, with Tris being the most common buffer reported [12, 24, 25, [31] [32] [33] [34] [35] . A well-known issue that arises when dissolving divalent metals in Tris, particularly at physiological pH, is the propensity of the freely exposed amine group of Tris to react with divalent metals and cause precipitation [36] . To investigate suitable buffers for determining the affinity and stoichiometry of divalent metal binding to HRG, isothermal titration calorimetry (ITC) was employed. No universal buffer for all divalent metals was identified. Although HRG bound to Zn 2+ and Cu 2+ in Bis-Tris HCl (pH 7.4), no binding was observed for Ni 2+ or Co 2+ , unless performed in HEPES buffer (pH 7.4) (Fig. S1) into buffer were performed (Fig. S2A-F) . The results showed no significant degree of reactivity for any of the divalent metals tested or problems with buffer mismatches. In summary, the optimal buffers for divalent metal binding to HRG (6) , and Co 2+ (13) ( Fig. 2A-D) .
HRG sensitivity to trypsin when coordinated with divalent metal
It has been reported that HRG is proteolytically regulated by serine proteases such as plasmin and suggested that Zn 2+ acts as shield to protect against proteolysis [21] . However recent data by Henderson et al. [8] demonstrated that plasmin is strongly inhibited by Zn 2+ . Therefore, to investigate the ability of Zn 2+ and other divalent metals to protect HRG against proteolytic digestion, we used trypsin as it has negligible inhibition by Zn 2+ or that of other Table 2 .
divalent metals [8] . Initially, to ensure trypsin activity was not affected by the divalent metals tested, human IgG was chosen as the control substrate for trypsin [29] . The proteolytic profiles of IgG in buffers supplemented with different concentrations of divalent metals (Zn 2+ , Cu
2+
, Ni 2+ and Co 2+ ) suggest that there was no significant impact on trypsin activity (Fig. S3) . HRG is~75 kDa under reducing conditions (Fig. 3A) and shows no fragmentation when analysed by SDS/PAGE under nonreducing conditions (Fig. 3B) . In the complete absence of metals, HRG is proteolytically cleaved by trypsin to an apparent single species of~45 kDa (Fig. 3A) . However, limited proteolysis of HRG was observed in the presence of each divalent metal. A unique banding profile for HRG by trypsin was observed in the presence of Zn 2+ (Fig. 3C ) that was distinct from that for Cu 2+ , Ni 2+ and Co 2+ , which all showed similar profiles as observed by SDS/PAGE analysis under reducing conditions (Fig. 3D-F) . These data infer similar recognition motifs of HRG by trypsin cleavage upon coordination with Cu 2+ , Ni 2+ or Co 2+ , which are different from those upon binding of Zn 2+ . Interestingly, when we examined the trypsin proteolysis of HRG in complex with each divalent metal by SDS/PAGE analysis under nonreducing conditions (Fig. 3G-J) , we observed different fragmented patterns for HRG when coordinated with each divalent metal. These unique patterns of HRG proteolytic fragments suggest the differential exposure and/or protection of trypsin recognition sites for each divalent metal-HRG complex. Fig. 3 . Sensitivity of HRG to trypsin in the presence of divalent metals. Trypsin (0.2 lg) digests of HRG (7.5 lg) were performed in 150 mM NaCl, 20 mM Bis-Tris HCl (pH 7.4) alone and for ZnCl 2 (50 lM) or CuCl 2 (50 lM) and 150 mM NaCl, 20 mM HEPES (pH 7.4) for CoCl 2 (50 lM) or NiCl 2 (50 lM). Trypsin digests were terminated by heating to 100°C, for 2 min, prior to adding reducing or nonreducing SDS loading dye. Samples were evaporated to < 20 lL, prior to loading the total remaining volume of the samples onto a 15% SDS/PAGE either under (A, C-F) reducing (black arrow shows differences for Zn 2+ , compared to other divalent metals) or (B, G-J) nonreducing conditions (black arrows point out the proteolytically released fragments from HRG).
Effects on the oligomerisation of HRG by Zn
2+
Based on our initial SEC analysis of HRG (Fig. 1) , the oligomeric state of HRG appears to be altered by coordination with divalent metals. This suggests that the type of divalent metal bound by HRG may result in a unique conformational change to promote the formation of higher order species (oligomers). In order to investigate changes in HRG oligomeric state, HRG was analysed by SEC in a buffer supplemented with 5 mM of Zn 2+ . Initially, the elution profile indicated HRG formed oligomers, i.e., dimer and trimer (Fig. 4A) . However, preincubating HRG with Zn 2+ , prior to analysis by SEC in a buffer not supplemented with Zn 2+ showed HRG reverted back to its single monomeric species (Fig. 4B ). These data suggest that the concentration of Zn 2+ that is supplemented in the buffer is regulating the formation of HRG oligomers. Therefore, the SEC of HRG was repeated in a buffer supplemented with 50 lM Zn 2+ to mimic physiological concentrations during wounding [8, 10, 11] . The SEC performed at this Zn 2+ (50 lM) concentration showed HRG to be in equilibrium as a monomer-dimer, with a bias towards the monomer (Fig. 4C) . The trypsin digest reaction was terminated by placing onto heat block (100°C) for 2 min, prior to adding reducing or nonreducing SDS loading dye. Samples were evaporated to < 20 lL, prior to loading the total remaining volume of the samples onto a 15% SDS/PAGE either under (D, E) reducing (black arrows show the differences between the two conditions) or (F, G) nonreducing conditions (black arrows highlight the differences in the number of fragments released between the two conditions).
( Fig. 2A) (Fig. 4C) .
Trypsin sensitivity to HRG in the presence of excess Zn
To determine if HRG dimerization changes the sensitivity of HRG to proteolysis, HRG 112 and HRG 50 were treated with trypsin and analysed by SDS/PAGE under reducing (Fig. 4D,E) and nonreducing (Fig. 4F,  G) conditions. In both cases, HRG 112 exhibited subtle differences in proteolytic profiles under reducing conditions ( Fig. 4D black arrows) and a greater number of released fragments under nonreducing conditions (Fig. 4G , black arrows) compared to HRG 50 (Fig. 4D,  F) . This suggests that the HRG 112 may expose new sites for trypsin proteolysis.
Effects on the oligomerisation of HRG in the presence of divalent metals other than Zn
To determine if higher oligomeric conformations of HRG also occur upon binding divalent metals other than Zn , none of the other divalent metals tested induced the formation of HRG oligomers (Fig. 5A) .
Regulation of HRG oligomerisation by pH
Histidine-rich glycoprotein has been shown to have pH sensing properties and acidic pH can regulate the ability of rbHRG to coordinate with divalent metal ions such as Zn 2+ [3, 15] . Therefore, to determine if HRG oligomerisation is regulated by acidic pH, HRG 112 was subject to SEC under different pH conditions of 7.4, 6.0 and 5.5 in buffer supplemented with 50 lM Zn 2+ (Fig. 5B) . The SEC profile showed that the monomer-dimer equilibrium of HRG 112 shifted towards the monomer at pH 6.0 and 5.5. This infers that pH is a factor in regulating the formation of HRG oligomers.
Discussion
The divalent metal Zn 2+ has been well characterized as an important regulator of HRG function, however the binding of other divalent metals to HRG has only been investigated in detail for the rbHRG orthologue [1, 4, 15, 30] . This is important to define, as HRG coordination with divalent metals other than Zn 2+ may similarly regulate function, particularly as the levels of divalent metals are increased in various physiological and pathological processes involving HRG [8, 11, 16, 18, 37] . The results presented in this study have identified a novel mechanism of how divalent metals may play a crucial role in modulating HRG function, particularly in the settings of tissue injury and tumour growth where divalent metals are differentially distributed [8, 11, 16, 27, 37, 38] .
The affinities (Table 2 ) of the divalent metals tested for HRG were Zn 2+ > Ni 2+ > Cu 2+ > Co 2+ . The number of binding sites of HRG for Zn 2+ (9-10 sites) was consistent from Kassaar et al. [12] and Horne et al. [13] observations of 10 Zn 2+ -binding sites, although our data show greater affinity for Zn 2+ (K d : 2.85 lM). This discrepancy could be a result of these previous studies using Tris as a buffer, which shows incompatibility for Zn 2+ as the reactive amine group of Tris can cause Zn 2+ to precipitate, particularly towards physiological pH [36] . To avoid this issue, we selected the buffer Bis-Tris HCl, on the basis of ITC results for the HRG-Zn 2+ interaction and that no visible precipitation was observed, possibly due to the five hydroxyl groups shielding the nitrogen core from free Zn 2+ . Using the Bis-Tris HCl buffer, the determined affinities of HRG for divalent metals did not follow the expected order of affinity from the Irving William series, with Ni 2+ exhibiting slightly greater affinity over Cu 2+ [18] . This observation might be attributed to the type of metal coordination geometries within the tertiary structure of HRG for the selection bias between Ni 2+ (Octahedral) and Cu 2+ (Square Planar), given both these divalent metals exhibit preference for the same ligand donors (nitrogen and oxygen) [18, 39] . Interestingly, the number of Cu 2+ sites is lower compared to the other divalent metals investigated. We note that Bis-Tris, which is known to harbour the capacity to form complexes with Cu 2+ [40] could potentially affect the number of Cu 2+ identified, however, we have not observed any obscuring effect from our experimental setup and the final number of Cu 2+ sites was determined after HRG was fully saturated. The order of Zn 2+ affinity was not unexpected, given Zn 2+ naturally contains greater ligand field stabilization energy over almost all divalent metals and hence rationalizes its position in the Irving William Series. However, the preferred Zn 2+ geometric configuration in proteins is tetrahedral, with the nitrogen (from histidines) as the favoured ligand donor [17] . This may also coincide and aid in HRG affinity towards Zn 2+ , considering the protein sequence of HRG constitutes 13% of histidines and the only ligand donor in the well-established metal-binding histidine-rich core [GHHPH-like motif, of which 11 are found in human HRG (Fig. S5) ] being a nitrogen [1, 17, 18] . Collectively, if there is a particular setting where there is an increase in the distribution of multiple divalent metals occurring simultaneously, such as observed in the serum of cancer patients [16] , HRG might have the capacity to bind multiple types of divalent metals, given that each of the divalent metals (except for Co 2+ ) exhibits very similar affinity for HRG. Therefore, as Zn 2+ levels are up-regulated at sites of tissue injury, and other divalent metals are observed in the serum of cancer patients, the potential interaction of HRG with different metals might reflect multiple roles in these settings [8, 11, 16, 37, 38] . The ability for HRG to be proteolytically processed by serine proteases to release individual functional domains has attracted significant interest, particularly in the context of antimicrobial, antiangiogenic and endotoxin-neutralizing activities [5, [23] [24] [25] [26] [27] 34, 41] . With the exception of plasmin, there is very little literature on the effects of many serine proteases such as protease 3, cathepsin G, thrombin, kallikrein and elastase on HRG [21, 25, 27, 42, 43] , and which of these enzymes may be regulating the release of HRG individual domains in vivo [27] . Interestingly, the recently solved N2-domain of the rabbit orthologue contains a glutathione adduct, suggesting that potential active domains may be released from HRG via redoxmediated processes [5] . We have observed that the released fragments from HRG following treatment with trypsin are influenced by the type of divalent metal HRG bound. It should be noted that trypsin is not a physiological serine protease that will act on HRG, however there are other endogenous serine proteases that target similar residues (Lys and Arg) such as plasmin or cathepsin G, which might be able to exhibit similar cleavage profiles of HRG in vivo [21, 43] . The trypsin-mediated proteolysis of Zn 2+ with HRG 50 was unexpected, particularly as Zn 2+ has been shown previously to protect HRG from plasmin proteolysis [21] . An explanation for this was observed in a recent study by Henderson et al. [8] illustrating Zn 2+ alone is capable of inhibiting plasmin activity [8] . Therefore, Zn 2+ may have been protecting HRG from plasmin proteolysis indirectly [8, 21] . However, the similar pattern of HRG processing by trypsin in the presence of each divalent metal (Cu 2+ , Ni 2+ and Co 2+ ), albeit different for Zn 2+ , suggests a common recognition motif that is exposed for proteolysis and subsequently gives rise to the release of fragments, each with the possibility of harbouring different biological roles.
Although proteolysis of HRG in complex with each divalent metal was capable of releasing fragments, only Zn 2+ was shown to induce oligomerization. This may not be considered surprising, given that an extensive search of oligomeric protein structures containing divalent metals, identified Zn 2+ in~40% of cases as the key mediator of higher oligomeric states, i.e. dimers, trimers and tetramers [19] . Importantly, the primary ligand donor found to facilitate higher quaternary structures/protein-protein interactions in the presence of Zn 2+ is the free thiol of cysteines [44] . These may have a role in Zn 2+ -mediated HRG oligomerization, as the disulphide bond arrangement for both HRG and rbHRG has been suggested to contain three additional half thiols [45] . Interestingly, these free thiols are mainly localized within the proline/histidine-rich regions, where a large proportion of metal-binding sites are predicted to be located [1, 45] . Therefore, the number and arrangement of free thiols that accommodate Zn 2+ might explain the Zn 2+ -regulated monomer-dimer equilibrium of HRG 112 . It should also be noted that the monomer-dimer equilibrium of HRG 112 altered how HRG was proteolysed by trypsin, suggesting that the dimeric conformation results in subtle changes in structure for trypsin to mediate the release of additional fragments from HRG. Furthermore, the molecular weight of these fragments from HRG 112 were between 30 and 40 kDa, which is similar to the expected molecular weight of the antiangiogenic domain that was observed in the serum of cancer patients by Thulin et al. [27] . This suggests that the up-regulation of Zn 2+ in tumour settings might play a role in regulating the release of HRG antiangiogenic domain [16, 27] .
It is well understood that HRG is exquisitely sensitive to changes to environmental pH, primarily due to the high content of histidines at its central core [1, 3, 46] . This is due to the pKa of the histidines (6.45) that influences whether HRG is positively charged (< 6.45) or negatively charged (> 6.45) at different pH [46] . Indeed, rbHRG shows complete association with Zn 2+ at alkali conditions (pH 7.4), 50% dissociation at pH 6.0 and almost complete dissociation at pH 5.5 (< 10%), demonstrating that pH is acting as a regulator on divalent metal coordination with HRG [15] . This supports the observation in the shift of the HRG 112 monomer-dimer equilibrium towards a monomer under acidic conditions. The significance of this might be observed through the different stages of the acute wound healing process, based on a study by Schneider et al. [47] that monitored the changes in pH at sites of tissue injury and observed significant fluctuations in pH throughout the stages that underpin the acute wound healing process [47] . These fluctuations in pH occur early in the wound healing processes, with an acidic milieu in the inflammatory phase, prior to normalizing towards physiological pH in the proliferation and re-epithelialization stage. Therefore, the changing pH may be differentially regulating HRG function, with positively charged roles of HRG occurring in the inflammatory stage, until the pH normalizes in the later stages to allow HRG-Zn 2+ coordinated activities [15, 47] .
In summary, the divalent metals Zn 2+ , Cu 2+ , Ni 2+ and Co 2+ were all capable of regulating biophysical properties of HRG. Importantly, Zn 2+ demonstrated the highest affinity for HRG and had a unique ability to promote the formation of HRG dimers and the proteolytic release of a greater number of HRG fragments. Therefore, as each of these divalent metals are prevalent in certain physiological and pathological settings, these findings begin to provide insight into how HRG biophysical attributes may be regulated during thrombolytic events, wound healing and tumourigenesis.
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